These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 28938941)

  • 1. Lecru L, Desterke C, Grassin-Delyle S, et al. Cannabinoid receptor 1 is a major mediator of renal fibrosis. Kidney Int. 2015;88:72-84.
    Kidney Int; 2017 Oct; 92(4):1018. PubMed ID: 28938941
    [No Abstract]   [Full Text] [Related]  

  • 2. Cannabinoid receptor 1 is a major mediator of renal fibrosis.
    Lecru L; Desterke C; Grassin-Delyle S; Chatziantoniou C; Vandermeersch S; Devocelle A; Vernochet A; Ivanovski N; Ledent C; Ferlicot S; Dalia M; Saïd M; Beaudreuil S; Charpentier B; Vazquez A; Giron-Michel J; Azzarone B; Durrbach A; François H
    Kidney Int; 2015 Jul; 88(1):72-84. PubMed ID: 25760323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yan Y, Ma L, Zhou X, et al. Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis. Kidney Int. 2016;89:68-81.
    Kidney Int; 2017 Sep; 92(3):770-772. PubMed ID: 28807271
    [No Abstract]   [Full Text] [Related]  

  • 4. The Role of Cannabinoid Receptors in Renal Diseases.
    Francois H; Lecru L
    Curr Med Chem; 2018; 25(7):793-801. PubMed ID: 28901271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of cannabinoid receptors in renal diseases].
    François H; Durrbach A; Beaudreuil S; Charpentier B; Lecru L
    Nephrol Ther; 2016 Apr; 12 Suppl 1():S115-22. PubMed ID: 26968477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angel-Korman A, Stern L, Sarosiek S, et al. Long-term outcome of kidney transplantation in AL amyloidosis. Kidney Int. 2019;95:405-411.
    Kidney Int; 2019 Sep; 96(3):796. PubMed ID: 31445586
    [No Abstract]   [Full Text] [Related]  

  • 7. The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases.
    Tam J
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):267-76. PubMed ID: 26280171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICAM-1 interactions in the renal interstitium: a novel activator of fibroblasts during nephritis.
    Clayton A; Steadman R
    Histol Histopathol; 1999 Jul; 14(3):861-70. PubMed ID: 10425556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CB1 cannabinoid receptor antagonist attenuates left ventricular hypertrophy and Akt-mediated cardiac fibrosis in experimental uremia.
    Lin CY; Hsu YJ; Hsu SC; Chen Y; Lee HS; Lin SH; Huang SM; Tsai CS; Shih CC
    J Mol Cell Cardiol; 2015 Aug; 85():249-61. PubMed ID: 26093151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary fibrosis in L-NAME-treated mice is dependent on an activated endothelin system.
    Kalk P; Mach A; Thone-Reineke C; Godes M; Heiden S; Sharkovska Y; von Websky K; Relle K; Hocher B
    Can J Physiol Pharmacol; 2008 Aug; 86(8):541-5. PubMed ID: 18758502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution on the correlation between morphometric parameters gained from the renal cortex and renal function in IgA nephritis.
    Mackensen-Haen S; Eissele R; Bohle A
    Lab Invest; 1988 Aug; 59(2):239-44. PubMed ID: 3404975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the connection between chronic renal fibrosis and bone morphogenic protein-7.
    Kalluri R; Zeisberg M
    Histol Histopathol; 2003 Jan; 18(1):217-24. PubMed ID: 12507301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of cannabinoid receptor type 2 by JWH133 alleviates bleomycin-induced pulmonary fibrosis in mice.
    Fu Q; Zheng Y; Dong X; Wang L; Jiang CG
    Oncotarget; 2017 Nov; 8(61):103486-103498. PubMed ID: 29262578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of endothelin-A receptor in human transplant renal arteriosclerosis.
    Nakatani T; Tanabe S; Han YS; Kayo S; Yoshimi N; Hai E; Shirai N; Ikura Y; Ohsawa M; Ueda M
    Int J Mol Med; 2003 Feb; 11(2):153-6. PubMed ID: 12525869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis.
    Teixeira-Clerc F; Julien B; Grenard P; Tran Van Nhieu J; Deveaux V; Li L; Serriere-Lanneau V; Ledent C; Mallat A; Lotersztajn S
    Nat Med; 2006 Jun; 12(6):671-6. PubMed ID: 16715087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases.
    Nettekoven M; Adam JM; Bendels S; Bissantz C; Fingerle J; Grether U; Grüner S; Guba W; Kimbara A; Ottaviani G; Püllmann B; Rogers-Evans M; Röver S; Rothenhäusler B; Schmitt S; Schuler F; Schulz-Gasch T; Ullmer C
    ChemMedChem; 2016 Jan; 11(2):179-89. PubMed ID: 26228928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone synthase gene polymorphism and renal histopathologic changes in kidney transplant patients receiving a calcineurin inhibitor.
    Ruiz-Palacios PC; Rodríguez-Castellanos FE; Mancilla-Urrea E; Avila-Casado Mdel C; Inofuentes-Rivero MX; Rodriguez-Illana F; Fragoso JM; Vargas-Alarcón G
    J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):301-6. PubMed ID: 23257211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G Protein-Coupled Receptor-G-Protein βγ-Subunit Signaling Mediates Renal Dysfunction and Fibrosis in Heart Failure.
    Kamal FA; Travers JG; Schafer AE; Ma Q; Devarajan P; Blaxall BC
    J Am Soc Nephrol; 2017 Jan; 28(1):197-208. PubMed ID: 27297948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of platelet-derived growth factor-CC in capillary rarefaction in renal fibrosis.
    Boor P; Bábíčková J; Steegh F; Hautvast P; Martin IV; Djudjaj S; Nakagawa T; Ehling J; Gremse F; Bücher E; Eriksson U; van Roeyen CR; Eitner F; Lammers T; Floege J; Peutz-Kootstra CJ; Ostendorf T
    Am J Pathol; 2015 Aug; 185(8):2132-42. PubMed ID: 26216283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oellgaard J, Gæde P, Rossing P, et al. Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits. Kidney Int. 2017;91:982-988.
    Kidney Int; 2017 May; 91(5):1257. PubMed ID: 28407880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.